STRUCTURE/FUNCTION OF CHROMATIN IN B-CELL DEVELOPMENT
Project Number5R29GM051165-02
Former Number1R29AI034448-01A1
Contact PI/Project LeaderBLASQUEZ, VERONICA C
Awardee OrganizationUNIVERSITY OF NOTRE DAME
Description
Abstract Text
The B-cell developmental system is a paradigm for understanding the
mechanisms that enable an organism to respond to extracellular signals.
Resting B-cells respond to antigenic stimuli by secretion of
immunoglobulin molecules. One of the hallmarks of this terminal
differentiation events is an increase in the expression of immunoglobulin
molecules reflected in the increased levels of mRNA. Although a large
number of studies have been exerted in elucidating the molecular basis
for this alteration in the level of gene expression, we still know very
little about the mechanisms involved in this process. Our studies of the
mouse kappa immunoglobulin locus has revealed that the structure of
chromatin around the 3' enchancer region is remarkably different in
antibody-secreting plasma B-cells compared with that of mature B-cells.
The DNAse I hypersensitive structure first observed in pro B-cells
persists at the mature B-cell stage but undergoes a transformation at
some stage between the differentiation of B-cells to plasma cells
resulting in the spreading of nuclease susceptible sites upstream and
downstream of the initial site. Since similar changes are detected in
terminally differentiated plasma cells expressing lamba chains, these
results suggest that the alteration in the 3'region is a differentiation-
dependent event. These changes in chromatin structure may underlie an
important aspect of B-cell end-differentiation an might bear upon kappa
gene expression. By a combination of reverse genetic, immunological,
cell biological, molecular biological, and biochemical techniques, we
hope to identify the molecular basis of these chromatin structural
changes. We have the unique opportunity to identify the factors that
participate in terminal differentiative events in B-cell development, the
external agents that these factors respond to, and their possible
mechanism of action on gene expression. Specifically, we wish to address
the following specific aims:
1) To determine the effects of extracellular stimuli (mitogens and
cytokines) on the chromosomal alterations observed during B-cell
maturation. This should lead to the establishment of an in vitro system
for studying the mechanisms involved in 3' enhancer induction.
2) To localize the DNA sequences within the 3" enhancer that define the
formation of DNAse I hypersensitive sites.
3) To identify the precise nucleotide sequences in contact with protein
factors in vivo genomic footprinting.
4) To identify and biochemically characterize the protein factors that
bind the DNA sequences identified in specific aim#2.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
B lymphocyteDNA binding proteinDNA footprintinganimal genetic material tagcell differentiationchemical structure functionchromatincytokinegenetic enhancer elementgenetic transcriptionimmunoglobulin geneslaboratory mousemitogenstissue /cell culture
No Sub Projects information available for 5R29GM051165-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R29GM051165-02
Patents
No Patents information available for 5R29GM051165-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R29GM051165-02
Clinical Studies
No Clinical Studies information available for 5R29GM051165-02
News and More
Related News Releases
No news release information available for 5R29GM051165-02
History
No Historical information available for 5R29GM051165-02
Similar Projects
No Similar Projects information available for 5R29GM051165-02